Analysis of biochemical parameters and tumor markers in Cushing’s disease and ectopic adrenocorticotropic hormone syndrome
PeerJ · 2026
DOI: 10.7717/peerj.21677 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2026. Verfasst von Linjia Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Qilu Hospital of Shandong University, Jinan City, Shandong Province, China. Hauptthemen laut MEDLINE: ACTH Syndrome, Ectopic, Biomarkers, Tumor, Pituitary ACTH Hypersecretion. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC) Regional Innovation and Development Joint Fund, National Natural Science Foundation of China, China Endocrine and Metabolic Talent Research Project.
Abstract (Originalsprache)
Purpose
To compare clinical characteristics, biochemical parameters, and tumor markers between patients with Cushing disease (CD) and ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS), identify potential biomarkers, and optimize their diagnostic differentiation.
Methods
A single-center retrospective study was conducted in 75 patients with ACTH-dependent Cushing syndrome (51 CD, 24 EAS) admitted between January 2006 and April 2025. Differences in biochemical indices, tumor markers, and hormone levels were analyzed. Receiver operating characteristic (ROC) analysis was used to evaluate diagnostic performance and determine optimal cut-off values.
Results
EAS patients were significantly older at diagnosis than CD patients. Fasting glucose was higher, while serum potassium and albumin were lower in the EAS group. Non–small cell lung cancer-associated antigen, carcinoembryonic antigen (CEA), cancer antigen 15-3 (CA15-3), and cancer antigen 19-9 were markedly elevated in EAS, whereas pro-gastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) showed no significant differences. Serum cortisol and plasma ACTH levels at all time points and after dexamethasone suppression were significantly higher in EAS. ROC analysis of the product of midnight serum cortisol (μg/dL) and plasma ACTH (pg/mL) divided by 1000 (“Midnight Cort × ACTH/1000”) showed an area under the curve (AUC) of 0.902 for identifying EAS, with a cut-off value >2 (sensitivity 83.3%, specificity 84.3%). Its diagnostic accuracy was comparable to that of the high-dose dexamethasone suppression test (HDDST).
Conclusion
EAS patients were older and exhibited more severe metabolic abnormalities than those with CD. Elevated tumor markers may suggest ectopic ACTH secretion. The “Midnight Cort × ACTH/1000” index provides high diagnostic value and a simple, convenient method for differentiating EAS from CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Qilu Hospital of Shandong University, Jinan City, Shandong Province, China.
ORCID-Profile: Yingqi Liu
Förderung
- National Natural Science Foundation of China (NSFC) Regional Innovation and Development Joint Fund
- National Natural Science Foundation of China
- China Endocrine and Metabolic Talent Research Project
- Shandong Provincial Natural Science Foundation
Zitieren
APA
Guo, L., Liu, Y., Li, S., Yu, X., Wang, K., & Yan, F. (2026). Analysis of biochemical parameters and tumor markers in Cushing’s disease and ectopic adrenocorticotropic hormone syndrome. PeerJ. https://doi.org/10.7717/peerj.21677
Vancouver
Guo L, Liu Y, Li S, Yu X, Wang K, Yan F. Analysis of biochemical parameters and tumor markers in Cushing’s disease and ectopic adrenocorticotropic hormone syndrome. PeerJ. 2026. doi:10.7717/peerj.21677
BibTeX
@article{Guo2026,
author = {Guo, Linjia and Liu, Yingqi and Li, Saijia and Yu, Xinyue and Wang, Kewei and Yan, Fei},
title = {Analysis of biochemical parameters and tumor markers in Cushing’s disease and ectopic adrenocorticotropic hormone syndrome},
journal = {PeerJ},
year = {2026},
doi = {10.7717/peerj.21677}
}
EUVIMED